557
Views
23
CrossRef citations to date
0
Altmetric
Review

Improvements in diagnostic tools for early detection of psoriatic arthritis

, , , , &
Pages 1209-1215 | Received 20 Mar 2016, Accepted 20 May 2016, Published online: 10 Jun 2016

References

  • Olivieri I, D’Angelo S, Palazzi C, et al. Advances in the management of psoriatic arthritis. Nat Rev Rheumatol. 2014;10:531–542.
  • Egeberg A, Khalid U, Gislason GH, et al. Association of psoriatic disease with uveitis: a Danish nationwide cohort study. JAMA Dermatol. 2015;151:1200–1205.
  • Li WQ, Han JL, Chan AT, et al. Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis. 2013;72:1200–1205.
  • Husni ME. Comorbidities in psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:677–698.
  • Scarpa R, Ayala F, Caporaso N, et al. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol. 2006;33:210–212.
  • Lubrano E, Cantini F, Costanzo A, et al. Measuring psoriatic disease in clinical practice. an expert opinion position paper. Autoimmun Rev. 2015;14:864–874.
  • Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014;74:423–441.
  • Olivieri I, D’Angelo S, Gilio M, et al. Relationship of psoriatic arthritis to other spondyloarthritides. J Rheumatol Suppl. 2015;93:33–35.
  • Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–2673.
  • Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:545–568.
  • Olivieri I, D’Angelo S, Padula A, et al. Spondyloarthritis with onset after age 45. Curr Rheumatol Rep. 2013;15:374.
  • McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford). 2003;42:778–783.
  • Gladman DD, Stafford-Brady F, Chang CH, et al. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol. 1990;17:809–812.
  • Torre-Alonso JC, Rodriguez-Perez A, Arribas Castrillo JM, et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991;30:245–250.
  • Wong K, Gladman DD, Husted J, et al. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum. 1997;40:1868–1872.
  • Gladman DD. Disability and quality of life considerations. Psoriatic arthritis. In: Gordon GB, Ruderman E, editors. Psoriasis and psoriatic arthritis: an integral approach. Heidelberg (Germany): Springer-Verlag; 2005. p. 118–123.
  • Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003;42:1460–1468.
  • Lindqvist UR, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register– 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol. 2008;35:668–673.
  • Geijer M, Lindqvist U, Husmark T, et al. The Swedish early psoriatic arthritis registry 5-year followup: substantial radiographic progression mainly in men with high disease activity and development of dactylitis. J Rheumatol. 2015;42:2110–2117.
  • Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045–1050.
  • D’Angelo S, Palazzi C, Olivieri I. Psoriatic arthritis: treatment strategies using biologic agents. Reumatismo. 2012;64:113–121.
  • Olivieri I, D’Angelo S, Padula A, et al. The challenge of early diagnosis of psoriatic arthritis. J Rheumatol. 2008;35:3–5.
  • McHugh NJ. Early psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:615–622.
  • Radtke MA, Reich K, Blome C, et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol. 2009;23:683–691.
  • Reich K, Kruger K, Mossner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160:1040–1047.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61:1373–1378.
  • Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72:736–740.
  • Spelman L, Su JC, Fernandez-Peñas P, et al. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice. J Eur Acad Dermatol Venereol. 2015;29:2184–2191.
  • Villani AP, Rouzaud M, Sevrain M, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73:242–248.
  • Husni ME, Meyer KH, Cohen DS, et al. The PASE questionnaire: pilot-testing a Psoriatic Arthritis Screening and Evaluation tool. J Am Acad Dermatol. 2007;57:581–587.
  • Dominguez PL, Husni ME, Holt EW, et al. Validity, reliability, and sensitivity-to change properties of the Psoriatic Arthritis Screening and Evaluation questionnaire. Arch Dermatol Res. 2009;301:573–579.
  • Gladman DD, Schentag CT, Tom BD, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2009;68:497–501.
  • Gladman DD, Helliwell PS, Khraishi M, et al. Dermatology screening tools: project update from the GRAPPA 2012 annual meeting. J Rheumatol. 2013;40:1425–1427.
  • Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol. 2009;27:469–474.
  • Khraishi M, Mong J, Mugford G, et al. The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients. J Cutan Med Surg. 2011;15:143–149.
  • Tinazzi I, Adami S, Zanolin EM, et al. The early Psoriatic Arthritis Screening Questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford). 2012;51:2058–2063.
  • Busquets-Pérez N, Marzo-Ortega H, Mcgonagle D, et al. CONTEST collaboration. Screening psoriatic arthritis tools: analysis of the Early ARthritis for Psoriatic Patients questionnaire. Rheumatology (Oxford). 2015;54:200–202.
  • Coates LC, Aslam T, Al Balushi F, et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol. 2013;168:802–807.
  • Coates LC, Walsh J, Haroon M, et al. Development and testing of new candidate Psoriatic Arthritis Screening Questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken). 2014;66:1410–1416.
  • Mease PJ, Gladman DD, Helliwell P, et al. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2014;71:649–655.
  • Acosta Felquer ML, FitzGerald O. Peripheral joint involvement in psoriatic arthritis patients. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S26–S30.
  • Olivieri I, Padula A, Scarano E, et al. Dactylitis or “sausage-shaped” digit. J Rheumatol. 2007;34:1217–1222.
  • Olivieri I, D’Angelo S, Scarano E, et al. What is the primary lesion in SpA dactylitis? Rheumatology (Oxford). 2008;47:561–562.
  • Salvarani C, Cantini F, Olivieri I, et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol. 1997;24:1106–1110.
  • D’Agostino MA, Olivieri I. Enthesitis. Best Pract Res Clin Rheumatol. 2006;20:473–486.
  • Lubrano E, Parsons WJ, Marchesoni A, et al. The definition and measurement of axial psoriatic arthritis. J Rheumatol Suppl. 2015;93:40–42.
  • Olivieri I, Padula A, D’Angelo S, et al. Psoriatic arthritis sine psoriasis. J Rheumatol Suppl. 2009;83:28–29.
  • Punzi L, Podswiadek M, Oliviero F, et al. Laboratory findings in psoriatic arthritis. Reumatismo. 2007;59(Suppl 1):52–55.
  • Korendowych E, Owen P, Ravindran J, et al. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford). 2005;44:1056–1060.
  • Inanc N, Dalkilic E, Kamali S, et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol. 2007;26:17–23.
  • Payet J, Goulvestre C, Bialé L, et al. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients. J Rheumatol. 2014;41:2395–2402.
  • FitzGerald O, Haroon M, Giles JT, et al. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17:115.
  • Olivieri I, Scarano E, Padula A, et al. Imaging of psoriatic arthritis. Reumatismo. 2007;59(Suppl 1):73–76.
  • Poggenborg RP, Østergaard M, Terslev L. Imaging in psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:593–613.
  • Olivieri I, D’Angelo S. Psoriatic arthritis in 2015: advancement continues in imaging, tight control and new drugs. Nat Rev Rheumatol. 2016;12:76–78.
  • Delle Sedie A, Riente L. Psoriatic arthritis: what ultrasound can provide us. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S60–S65.
  • Gutierrez M, Draghessi A, Bertolazzi C, et al.; Pan-American League Against Rheumatisms (PANLAR) Ultrasound Study Group. Ultrasound in psoriatic arthritis. Can it facilitate a best routine practice in the diagnosis and management of psoriatic arthritis? Clin Rheumatol. 2015;34:1847–1855.
  • Litinsky I, Balbir-Gurman A, Wollman J, et al. Ultrasound assessment of enthesis thickening in psoriatic arthritis patients treated with adalimumab compared to methotrexate. Clin Rheumatol. 2016;35:363–370.
  • Poggenborg RP, Sørensen IJ, Pedersen SJ, et al. Magnetic resonance imaging for diagnosing, monitoring and prognostication in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(5Suppl 93):S66–S69.
  • McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet. 1998;352:1137–1140.
  • Tan AL, Grainger AJ, Tanner SF, et al. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum. 2006;54:1328–1333.
  • Narváez J, Narváez JA, de Albert M, et al. Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease? Semin Arthritis Rheum. 2012;42:234–245.
  • Braum LS, McGonagle D, Bruns A, et al. Characterisation of hand small joints arthropathy using high-resolution MRI–limited discrimination between osteoarthritis and psoriatic arthritis. Eur Radiol. 2013;23:1686–1693.
  • McGonagle D, Hermann KG, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford). 2015;54:29–38.
  • Mandl P, Navarro-Compán V, Terslev L, et al.; European League Against Rheumatism (EULAR). EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74:1327–1339.
  • Taylor WJ, Marchesoni A, Arreghini M, et al. A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum. 2004;34:575–584.
  • D’Angelo S, Ferrante MC, Atteno M, et al. The performance of CASPAR criteria in early psoriatic arthritis: preliminary results from an Italian prospective multicentre study. Ann Rheum Dis. 2008;67(Suppl 2):525.
  • Coates LC, Conaghan PG, Emery P, et al. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 2012;64:3150–3155.
  • Palazzi C, Lubrano E, D’Angelo S, et al. Beyond early diagnosis: occult psoriatic arthritis. J Rheumatol. 2010;37:1556–1558.
  • Palazzi C, D’Angelo S, Lubrano E, et al. New insights in occult psoriatic arthritis. J Rheumatol Suppl. 2012;89:22–23.
  • Eder L, Chandran V, Pellett F, et al. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Ann Rheum Dis. 2012;71:1361–1365.
  • Chandran V, Bull SB, Pellett FJ, et al. Human leukocyte antigen alleles and susceptibility to psoriatic arthritis. Hum Immunol. 2013;74:1333–1338.
  • Haroon M, Winchester R, Giles JT, et al. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis. 2016;75:155–162.
  • Jadon DR, Nightingale AL, McHugh NJ, et al. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol. 2015;42:21–30.
  • Generali E, Scirè CA, Favalli EG, et al. Biomarkers in psoriatic arthritis: a systematic literature review. Expert Rev Clin Immunol. 2016;24:1–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.